1. HIV treatment engagement in the context of COVID-19: an observational global sample of transgender and nonbinary people living with HIV
- Author
-
Sean Howell, Chase Childress, Gregorio A. Millett, Stefan Baral, Arjee Restar, Tyler Adamson, S. Wilson Beckham, Jennifer L. Glick, Henri M. Garrison-Desany, and Brooke A. Jarrett
- Subjects
medicine.medical_specialty ,Context (language use) ,HIV Infections ,Transgender Persons ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,Transgender ,medicine ,Humans ,030212 general & internal medicine ,Medical prescription ,Socioeconomic status ,Pandemics ,030505 public health ,business.industry ,SARS-CoV-2 ,Public health ,Research ,Public Health, Environmental and Occupational Health ,virus diseases ,COVID-19 ,HIV ,Coronavirus ,Family medicine ,Transgender people living with HIV ,Observational study ,Public aspects of medicine ,RA1-1270 ,Biostatistics ,0305 other medical science ,business - Abstract
Background HIV services, like many medical services, have been disrupted by the COVID-19 pandemic. However, there are limited data on the impacts of the COVID-19 pandemic on HIV treatment engagement outcomes among transgender (trans) and nonbinary people. This study addresses a pressing knowledge gap and is important in its global scope, its use of technology for recruitment, and focus on transgender people living with HIV. The objective of this study is to examine correlates of HIV infection and HIV treatment engagement outcomes (i.e., currently on ART, having an HIV provider, having access to HIV treatment without burden, and remote refills) since the COVID-19 pandemic began. Methods We utilized observational data from the Global COVID-19 Disparities Survey 2020, an online study that globally sampled trans and nonbinary people (n = 902) between April and August 2020. We conducted a series of multivariable logistic regressions with lasso selection to explore correlates of HIV treatment engagement outcomes in the context of COVID-19. Results Of the 120 (13.3%) trans and nonbinary people living with HIV in this survey, the majority (85.8%) were currently on HIV treatment. A smaller proportion (69.2%) reported having access to an HIV provider since COVID-19 control measures were implemented. Less than half reported being able to access treatment without burdens related to COVID-19 (48.3%) and having the ability to remotely refill HIV prescription (44.2%). After adjusting for gender in the multivariable models, younger age and anticipated job loss were significantly associated with not having access to HIV treatment without burden. Outcomes also significantly varied by geographic region, with respondents reporting less access to an HIV provider in nearly every region outside of South-East Asia. Conclusion Our results suggest that currently taking ART, having access to an HIV provider, and being able to access HIV treatment without burden and remotely refill HIV medication are suboptimal among trans and nonbinary people living with HIV across the world. Strengthening support for HIV programs that are well-connected to trans and nonbinary communities, increasing remote access to HIV providers and prescription refills, and providing socioeconomic support could significantly improve HIV engagement in trans and nonbinary communities.
- Published
- 2021